Analyst Research

Report Title Price
Provider: Stock Traders Daily
$20.00
Provider: Thomson Reuters Stock Report
$25.00
Provider: ValuEngine, Inc.
$25.00
Provider: Pechala's Reports
$25.00

NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.

GenMark Diagnostics Inc Lowers FY 2013 Revenue Guidance


Tuesday, 12 Nov 2013 04:02pm EST 

GenMark Diagnostics Inc announced that for fiscal 2013, it expects adjusting revenue guidance to approximately $27 million. According to I/B/E/S Estimates, analysts are expecting the Company to report revenues of $29 million for fiscal 2013. 

Company Quote

9.43
0.29 +3.17%
10:45am EDT